CAPTOPRIL (Windlas Healthcare (P) Ltd.)
Welcome to the PulseAid listing for the CAPTOPRIL drug offered from Windlas Healthcare (P) Ltd.. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Windlas Healthcare (P) Ltd. |
NON-PROPRIETARY NAME: | captopril |
SUBSTANCE NAME: | CAPTOPRIL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1997-03-28 |
END MARKETING DATE: | 0000-00-00 |
CAPTOPRIL HUMAN PRESCRIPTION DRUG Details:
Item Description | CAPTOPRIL from Windlas Healthcare (P) Ltd. |
LABELER NAME: | Windlas Healthcare (P) Ltd. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 12.5(mg/1) |
START MARKETING DATE: | 1997-03-28 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57721-902_9978c84f-2a21-45fa-a197-a7e7b1152e03 |
PRODUCT NDC: | 57721-902 |
APPLICATION NUMBER: | ANDA074532 |
Other CAPTOPRIL Pharmaceutical Manufacturers / Labelers: